Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2018 Filed Mar 15, 2018 21:25 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
PurchaseCommon Stock | 17,911 | $5.19 | $92,958.09 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,570,491 F3 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.15 to $5.23 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 10,031 | $5.05 | $50,656.55 |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · nonDerivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,779 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 2,674 | $5.05 | $13,503.70 |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · nonDerivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,825 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 2,650 | $5.05 | $13,382.50 |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · nonDerivative · entry 4 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,628 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 2,623 | $5.05 | $13,246.15 |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · nonDerivative · entry 4 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,841 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 2,648 | $5.05 | $13,372.40 |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · nonDerivative · entry 4 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,652 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 21:25 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
PurchaseCommon Stock | 90,000 | $5.13 | $461,475.00 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,552,580 F2 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.03 to $5.17 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · derivative · entry 6 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 28,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 7,735 | $4.80 | $37,138.06 |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,685 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $4.9452 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · derivative · entry 4 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · derivative · entry 6 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,499 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 2,063 | $4.80 | $9,905.49 |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,999 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $4.9652 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · derivative · entry 6 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · nonDerivative · entry 3 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 1,960 | $4.80 | $9,410.74 |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · nonDerivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,095 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $4.9501 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · derivative · entry 6 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F7 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F7 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · nonDerivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 2,063 | $4.80 | $9,905.29 |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,964 F3 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $4.957 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · derivative · entry 6 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F6 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F6 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 1,032 | $4.80 | $4,955.15 |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 F2 · shares: Represents the number of shares required to be sold to cover the statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.80 to $4.9552 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:22 UTC |
Jayaraman Vivek KChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019470 · doc4.xml · derivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2018. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 01:22 UTC |
Jayaraman Vivek KChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019470 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 2,779 shares, 5,773 shares and 4,982 shares purchased under Issuer's Employee Stock Purchase Plan on 2/28/17, 8/31/17 and 2/28/18, respectively. Read SEC document |
| March 12, 2018 Filed Mar 15, 2018 21:25 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
PurchaseCommon Stock | 10,000 | $4.95 | $49,483.00 |
DisclosureSEC source: 0001209191-18-019907 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462,580 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.86 to $4.95 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · derivative · entry 5 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:28 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionCommon Stock | 22,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019477 · doc4.xml · nonDerivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 4,982 shares purchased under Issuer's Employee Stock Purchase Plan on 2/28/18. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · derivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F3 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019475 · doc4.xml · nonDerivative · entry 1 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,445,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 1,089 shares purchased under Issuer's Employee Stock Purchase Plan on 8/31/17. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · derivative · entry 5 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019474 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · derivative · entry 5 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Underlying: Common Stock · 5,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:26 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 5,701 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019473 · doc4.xml · nonDerivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 3711 shares, 201 shares, 3003 shares, and 2768 shares purchased under Issuer's Employee Stock Purchase Plan on 8/31/16, 2/28/17, 8/31/17, and 2/28/18, respectively. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · derivative · entry 5 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:25 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019472 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 1,683 shares and 4,761 shares purchased under Issuer's Employee Stock Purchase Plan on 8/31/17 and 2/28/18, respectively. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · derivative · entry 5 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F5 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 10, 2017. Read SEC document |
| March 10, 2018 Filed Mar 14, 2018 01:23 UTC |
Benjamin Richard JChief Medical Officer
|
Exercise / conversionCommon Stock | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-019471 · doc4.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:58 UTC |
Moore CarolSVP Reg. & Quality
|
GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018124 · doc4.xml · derivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:58 UTC |
Moore CarolSVP Reg. & Quality
|
GrantOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018124 · doc4.xml · derivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:57 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018121 · doc4.xml · derivative · entry 2 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:57 UTC |
Jensen ChrystalChief Legal Officer
|
GrantOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018121 · doc4.xml · derivative · entry 1 Menard Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:57 UTC |
Jayaraman Vivek KChief Commercial Officer
|
GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018116 · doc4.xml · derivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:57 UTC |
Jayaraman Vivek KChief Commercial Officer
|
GrantOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018116 · doc4.xml · derivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:56 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 215,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018111 · doc4.xml · derivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 Underlying: Common Stock · 215,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:56 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantOption (Right to Buy) · Derivative | 430,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018111 · doc4.xml · derivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,000 Underlying: Common Stock · 430,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:55 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018107 · doc4.xml · derivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:55 UTC |
Green Kevin DennisChief Financial Officer
|
GrantOption (Right to Buy) · Derivative | 95,000 | Not disclosed Strike: $4.32 | Not disclosed |
DisclosureSEC source: 0001209191-18-018107 · doc4.xml · derivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2028-02-28 F2 · price: Not applicable. F1 · derivative.exercise_date: One eighth (1/8th) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest on each monthly anniversary of the transaction date thereafter. Read SEC document |
| March 01, 2018 Filed Mar 8, 2018 21:54 UTC |
CORASH LAURENCE MDirector · Chief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 47,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-018104 · doc4.xml · derivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 47,500 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. F4 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.